The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BTOG 2025 | From pathologist to patient: navigating molecular testing in lung cancer care
Adam Januszewski, St Bartholomew’s Hospital, London, UK, comments on the importance of understanding the molecular testing pathway in lung cancer care, highlighting the need for clinicians to be empowered to interpret pathology and clinical results, and to communicate effectively with patients about the process and its impact. This interview took place at the BTOG 2025 congress in Belfast, UK..
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
